- Price
- $172.40
- Day
- -0.80%
- Mkt Cap
- $15.79B
- 52W Range
- $157.10 – $241.82
- Volume
- 1.42M
- Beta
- 0.76
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
BWX Technologies, Inc. (BWXT) Q2 2026 Earnings Call Transcript
Read full article
BWX Technologies is one of the most well-rounded plays in the nuclear market.
Read full article
BWXT raises its 2026 outlook as stronger operations support higher guidance, while a medical divestiture and PCG deal sharpen its nuclear focus.
Read full article
LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) announced today it has entered into a definitive agreement to sell its medical business to Nordic Capital, an experienced healthcare investor with broad expertise and a deep understanding of the radiopharmaceutical industry and its value chain. The transaction, valued at up to $800 million, includes BWXT Medical and Kinectrics' stable medical isotopes business. The sale will enable BWXT to concentrate resources and capital on.
Read full article
LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2026 results. A reconciliation of non-GAAP results is detailed in Exhibit 1. “We had strong second quarter 2026 results that were ahead of our expectations,” said Rex. D. Geveden, president and chief executive officer. “Once again we saw strong execution across our business, high growth in Commercial Operations, and good free cash flow generation.” “Demand for new n.
Read full article
BWX Technologies NYSE: BWXT reported second-quarter 2026 revenue growth of 18% and raised its full-year financial outlook, citing continued demand across nuclear national security and commercial power markets.
Read full article
BWX Technologies (BWXT) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.02 per share a year ago.
Read full article
BWXT heads into Q2 with nuclear, medical and defense demand supporting sales, while earnings are expected to edge lower.
Read full article
Vertiv's latest quarter hit $3.3 billion as data center demand surges, while BWX Technologies maintains steady defense contracts.
Read full article
BWX Technologies currently shows a much stronger and more established baseline for revenue generation, while Archer Aviation is only just beginning to report recognizable sales figures. BWX Technologies experienced consistent quarter-over-quarter revenue progression over the past two years, whereas Archer Aviation recorded zero revenue until the final two quarters of the tracked period.
Read full article
Bank of Nova Scotia bought a new stake in shares of BWX Technologies, Inc. (NYSE: BWXT) during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 100,200 shares of the technology company's stock, valued at approximately $20,490,000. Bank of Nova Scotia owned about
Read full article
XE and BWXT offer two distinct paths into the growing nuclear sector, from advanced reactor development to established government-backed nuclear operations.
Read full article